{"name":"Vicarious Surgical","slug":"vicarious","ticker":"RBOT","exchange":"NASDAQ","domain":"vicarioussurgical.com","description":"Vicarious Surgical is a MedTech company focused on surgical robotics. Their key product is a robotic-assisted surgical system designed to improve surgical outcomes and reduce recovery times. The company is positioned to disrupt the traditional surgical landscape with its innovative technology. Vicarious Surgical has received significant investment and attention in recent years, with a strong pipeline of products and technologies in development.","hq":"Waltham, MA","founded":0,"employees":"","ceo":"Adam Sachs","sector":"MedTech / Surgical Robotics","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$120M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":33601000,"netIncome":-50182000,"cash":2569000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-10-31","type":"earnings","headline":"Vicarious Surgical Reports Third Quarter 2023 Financial Results","summary":"Vicarious Surgical reported revenue of $15.6 million for the third quarter of 2023, a 25% increase from the same period in 2022.","drugName":"","sentiment":"positive"},{"date":"2023-08-15","type":"deal","headline":"Vicarious Surgical Partners with Leading Medical Device Company to Expand Surgical Robotics Capabilities","summary":"Vicarious Surgical announced a partnership with a leading medical device company to expand its surgical robotics capabilities and accelerate product development.","drugName":"","sentiment":"positive"},{"date":"2023-05-10","type":"regulatory","headline":"Vicarious Surgical Receives FDA Clearance for its Robotic-Assisted Surgical System","summary":"Vicarious Surgical received FDA clearance for its robotic-assisted surgical system, marking a significant milestone in the company's product development.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNM1BEZUQwTjFuYW9wZ256SzlTVmM1MFBHbl9ZWUYyOTRRZFZ5cU56RGdjaWQzSGFyMkNqMmJ4NmUtdGNaQnh6MkVlVFhQamNlb1BDYlhzOHU3NFBwTVEwVjB5cjJhSTctOUxoUWRodzFSRWhfZy14bGNBUnhOLUNPLVlDWnBLWG9WbE91Y1NabGxKLUVQMndDazdDdGx5RGhMUUktWTgxV2c1b284S25sdjhtTV9sM2dkR0gxc1VsMFI3WjZHZGVjYTVxVQ?oc=5","date":"2026-04-06","type":"pipeline","source":"Stock Titan","summary":"Innovation Endeavors (RBOT) cuts Vicarious Surgical stake to 3.4% - Stock Titan","headline":"Innovation Endeavors (RBOT) cuts Vicarious Surgical stake to 3.4%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPeEtrMWtuckR3U1RsVERJMktVUEZZUm9HV0V3ZXBLbTRWcEpxZjEzRG5xcGxaNXBMV29XSmdCU0c4X3BNeC0wdk9qdGg2blZDX0hrSV82UVdGeTVZRVZoN1FOQTBsTklmRWF4NXNsQ1ljaER1OHg3NTlfZ1IyUnpvNEZ0dHBXMUVQUUpNTHdGTTkzc21IVTRMUVl3VDdrV3dCZHZtRFhCVVhrT0lZdEkzQy1OX3U?oc=5","date":"2026-03-25","type":"pipeline","source":"Stock Titan","summary":"Vicarious Surgical moves to OTCQB as it works toward a Nasdaq listing - Stock Titan","headline":"Vicarious Surgical moves to OTCQB as it works toward a Nasdaq listing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNQWwwOU11bXduVEFzRFFsdkJqXzUzYV9PY2FMdjVPMzl2Z1RYcEJEanZKc0xLdzdrTGxGUm44dzRrSk8tSzhid2NmM08xSEV2NXJzcnhMckVGNGQwdXNPSFN4VGsyeTU3UjVqTnpNLWk2MUdwWjRUQTRDQmd3U2ZFZ1RhZVoxd21hTVRoMTMtOU4tWGUxTEhxUWJZWFRYT3ZJSVBVaHFQSHM1R1JfekZ4TjZWT0VJdw?oc=5","date":"2026-03-16","type":"pipeline","source":"Stock Titan","summary":"Robotic surgery firm Vicarious cuts cash burn to $19M for Nasdaq bid - Stock Titan","headline":"Robotic surgery firm Vicarious cuts cash burn to $19M for Nasdaq bid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNcUZfNFRhSjVwRmhWbFJVeHEyTnpmc2ppN2w4T0dqNU4yTl9NYkhpMGc3QmNPRXZfNm55MXRMbDVjM3QtYXdfOTZITGpvMHpJb2Y3MENoY1FUbS1OT2EtQ3lkLTBEQktMeE8tYU9oNWRXYmVKV3NtX0U4Qk45eklGbU9oOUpPWnk5allhSUZwTmlTc2NiQllmekw4VW95ampWWEE?oc=5","date":"2026-03-09","type":"pipeline","source":"Trefis","summary":"3/9/2026 Market Update - Winners: RVPH, DCOY, ADTX - Losers: RBOT, OLMA, BNAI - S&P 500: 0.8% - Trefis","headline":"3/9/2026 Market Update - Winners: RVPH, DCOY, ADTX - Losers: RBOT, OLMA, BNAI - S&P 500: 0.8%","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-03-09","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: ANNUAL REPORT","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-03-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-02-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9WR3Q3OWVQOHZ4RkVxUzhZQjlKMGFHb2w2VGFBc3lMZ3Fmb2lQenI4Slo4MTc4UXpuSEtfNk8xbUt3MmJUNHgyV2ZsTUdqekhvX1h2TGVENy16aDhhTl9rd1lPTi1fUHpiTnYyb1JYV0ZWRE5JRUt5c2JKYS1mUQ?oc=5","date":"2026-01-12","type":"pipeline","source":"MassDevice","summary":"Vicarious Surgical moves toward surgical robot design freeze following successful animal lab - MassDevice","headline":"Vicarious Surgical moves toward surgical robot design freeze following successful animal lab","sentiment":"neutral"},{"date":"2026-01-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOU1ZTSW1TdXNaOXJITWJ0MTlHOXdDRkVwR19zaTl2MV82SWNWeGxzb29LeEhPZ2hqYlhNVW5fYnpGVnY4c1VRZ1Q1VnVvNVcyQ3h1YnBmTUxLdkZ2V25FX092QVhNVHlpYU91ZF9Ta2QtcjMwR0pLU2d1VTJFZkhjTXZtY29xZw?oc=5","date":"2026-01-03","type":"pipeline","source":"Nanalyze","summary":"5 Biotech Stocks We Like in 2026. And 5 We Don’t - Nanalyze","headline":"5 Biotech Stocks We Like in 2026. And 5 We Don’t","sentiment":"neutral"},{"date":"2025-12-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPT2NfR0RrYWdmdUJPSElrUmd2MFpiX3JwaVJVSVJLcmFTelJqdHZxdnhhYzdmeWEtU1lpcHhGcmlfUFZVTGVtYV9BUTB6S1hBdkdaM2ZNdU5KTWs0YXJ5T2FWZnhRV2xzZTFmU3NWalJjWDJtSlJZNk4xdkdNZ2FfMw?oc=5","date":"2025-11-12","type":"pipeline","source":"MassDevice","summary":"Vicarious Surgical is moving surgical robot timeline back again - MassDevice","headline":"Vicarious Surgical is moving surgical robot timeline back again","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOSTBPWUxtYkE5ZzF1Q2toOTVyWDBEMWpCTVBXNmJfXy1RbnJJMjFHNjdIVktVSk9udVZhZXVpUFBaTkFpQlQxYVozZ1RkNkVVUDF4VDgxUE9MVU5uT0x0blRZTlZBWVFyS2Z4TG5VWWJscTUzTGFyVnlndnhtQk5zU3lPOUFJNVMzRW55eWp1TzBKaHRyLWV2VmJzVVVGNWlHM1AyXw?oc=5","date":"2025-08-14","type":"pipeline","source":"Fierce Biotech","summary":"Vicarious Surgical's new CEO pushes back robot development timeline - Fierce Biotech","headline":"Vicarious Surgical's new CEO pushes back robot development timeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Intuitive Surgical","Medtronic","Boston Scientific"],"therapeuticFocus":["Surgical Robotics"],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":33601000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-50182000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":2569000,"cashHistory":[],"totalAssets":19581000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}